Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does TREPROSTINIL Cause Post procedural complication? 174 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 174 reports of Post procedural complication have been filed in association with TREPROSTINIL (TYVASO). This represents 0.2% of all adverse event reports for TREPROSTINIL.

174
Reports of Post procedural complication with TREPROSTINIL
0.2%
of all TREPROSTINIL reports
28
Deaths
119
Hospitalizations

How Dangerous Is Post procedural complication From TREPROSTINIL?

Of the 174 reports, 28 (16.1%) resulted in death, 119 (68.4%) required hospitalization, and 9 (5.2%) were considered life-threatening.

Is Post procedural complication Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for TREPROSTINIL. However, 174 reports have been filed with the FAERS database.

What Other Side Effects Does TREPROSTINIL Cause?

Dyspnoea (16,348) Headache (14,051) Diarrhoea (11,335) Nausea (10,320) Cough (8,945) Fatigue (7,440) Dizziness (7,405) Infusion site pain (5,169) Vomiting (5,097) Death (4,764)

What Other Drugs Cause Post procedural complication?

ADALIMUMAB (2,494) ETANERCEPT (318) CALCIUM\DEXTROSE\MAGNESIUM\SODIUM\SODIUM (244) UPADACITINIB (241) RISANKIZUMAB-RZAA (232) INFLIXIMAB (217) METHOTREXATE (188) HUMAN IMMUNOGLOBULIN G (159) PREDNISONE (157) CARBIDOPA\LEVODOPA (156)

Which TREPROSTINIL Alternatives Have Lower Post procedural complication Risk?

TREPROSTINIL vs TREPROSTINIL DIOLAMINE TREPROSTINIL vs TRETINOIN TREPROSTINIL vs TRIAMCINOLONE TREPROSTINIL vs TRIAMCINOLONE ACETONIDE TREPROSTINIL vs TRIAMCINOLONE HEXACETONIDE

Related Pages

TREPROSTINIL Full Profile All Post procedural complication Reports All Drugs Causing Post procedural complication TREPROSTINIL Demographics